Henan University of Technology
Zhengzhou, Henan, 450001, China
NCT Number: NCT06103240
Purpose: to verify the physiological properties of Lactobacillus rhamnosus LRa05.
Bacterial count:100 billion Test Objective: to test and collect the changes of intestinal flora before and after the daily use of LRa05 product.
Looking for future studies?
Notify Me19 year–45 year
All sexes
Interventional
Not applicable
Zhengzhou, Henan, 450001, China
In order to validate the physiological properties of the 100 billion probiotic Lactobacillus rhamnosus LRa05 product and to gather sufficient evidence to test the changes in the intestinal flora before and after the daily use of the probiotic product, the test was conducted on 110 college students aged 18-25 years.
The primary outcome was to investigate the increase in the diversity of the gut flora and the increase in the peak levels of beneficial bacteria in the gut, and the secondary outcome was to investigate whether there was a significant improvement in the PSQI Pittsburgh Sleep Quality Index and the ISI Insomnia Severity Index.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bacterial count:100 billion CFUs Take one sachet per day for 4 weeks.
Time frame: 4 weeks
Subjects took a packet of probiotics every day. Before taking probiotics, two weeks after taking probiotics, and after taking probiotics, fecal samples were collected, and fecal 16s rRNA was extracted using a DNA kit.
Wecare Probiotics Co., Ltd.
Industry
Changes in the Gut Microbiota Composition of Healthy Young Volunteers After Administration of Lacticaseibacillus Rhamnosus LRa05: A Placebo-controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05843591
Exercise Intervention, Intestinal Flora
Hefei, Anhui, China
View Trial DetailsNCT07648394
Anorectal Diseases, Constipation
Beijing, Chaoyang District, China
View Trial DetailsNCT07581756
Chronic Diarrhea, Colonic Diseases
Suzhou, Jiangsu, China
View Trial DetailsNCT06960369
Chronic Diarrhea, Colonic Diseases
Suzhou, Jiangsu, China
View Trial Details